At a glance
When low AMH and elevated sperm DNA fragmentation appear in the same couple, a Thailand IVF plan has to hold two separate clinical questions at once. Here is how clinicians tend to approach it, what records matter, and what to settle before you travel.
Low AMH and a high sperm DNA fragmentation result are two different findings about two different people. They are not a single combined diagnosis, and there is no standard recipe that a clinic applies when both appear together. What a Thailand IVF plan can do is treat each finding as its own clinical question, then work out where the two questions meet: at the embryo.
That meeting point is why the planning conversation is more specific than either finding alone. Low AMH speaks to how many eggs may be available to work with. Sperm DNA fragmentation speaks to the integrity of the DNA carried inside the sperm. A cycle has to produce embryos from both, so the plan has to consider egg numbers and sperm handling in the same discussion rather than in two separate appointments.
Why the two findings are assessed separately before they are assessed together
AMH is a blood marker that gives an indication of ovarian reserve — broadly, the size of the egg pool a woman is working with. It does not measure egg quality, and it does not predict whether any single egg will form a healthy embryo. A low result mainly shapes expectations about how many eggs a stimulation cycle might yield, which in turn shapes how many embryos might be available for transfer or testing.
Sperm DNA fragmentation is measured differently. A fragmentation index describes the proportion of sperm in a sample with detectable DNA breaks. The test methods and the way results are interpreted are not standardised, which is a point the HFEA makes in its guidance on sperm DNA fragmentation and sperm selection. That matters for planning: a number from one laboratory is not automatically comparable with a number from another, so the assay used and the reference range belong in the conversation.
Only after each result is understood on its own terms does it make sense to ask how they interact. A couple with limited expected egg numbers and a raised fragmentation index is working with two constraints on the same embryo-creation step. Neither constraint can be read off the other, and neither can be converted into a single probability.
No combined success figure exists, and clinic statistics do not transfer
A clinic may publish outcomes for low ovarian reserve, or for male factor, or for its IVF programme overall. None of those figures describes a couple with both findings. Published statistics are built from populations with particular mixes of age, diagnosis, protocol and laboratory practice; a couple with two concurrent findings is not that population.
This is worth saying plainly because it is the most common place where planning goes wrong. A number that sounds reassuring for one factor is not evidence for the pair, and a number that sounds discouraging is not a verdict either. What clinicians can do is interpret your specific results, explain what each one changes about the plan, and give an individual view of chances — with the honest caveat that individual chances are estimates, not promises. Ask for that view directly; it is a clinical question, and licensed clinicians are the right people to answer it.
Records to assemble before a Thai consultation
The quality of a first remote consultation depends heavily on what the clinician can see. For this combination of findings, a useful file usually includes:
- AMH result with the date, the laboratory, and the units used.
- Antral follicle count from ultrasound, if one has been done, with the date and who performed it.
- Prior stimulation response, if there has been an earlier IVF cycle: dose, protocol, number of eggs retrieved, and how many embryos formed.
- Semen analysis results, including count, movement and morphology, with dates.
- The sperm DNA fragmentation result, including the assay method used, the reference range, and the date — not just the headline percentage.
- Prior cycle and embryo outcomes, including any PGT results, if testing was done before.
- Relevant history such as age, previous surgery, or conditions either partner already knows about.
If a fragmentation result exists without the assay details, it is reasonable to ask the original laboratory for the full report before sharing it. A number without its method is hard for a clinician to weigh.
What to raise about stimulation when egg numbers may be limited
With low AMH, the stimulation discussion tends to centre on realism rather than on finding a protocol that defeats biology. Useful topics include how the clinic would choose a starting dose and protocol given the prior response, if any; what monitoring looks like and how decisions are made mid-cycle; and what the clinic does if the response is lower than hoped.
It is also fair to ask how the clinic thinks about cycle cancellation and whether a converted or adjusted plan is possible. A plan that only works if a high number of eggs appears is a fragile plan for this couple. The more useful question is what the decision tree looks like at each monitoring point.
For a broader look at how egg number fits into the conversation, see why egg number is only one part of an IVF discussion about low ovarian reserve.
Sperm selection, ICSI and the laboratory conversation
On the male side, the questions are about handling rather than about a single fix. Couples commonly ask whether a special sperm-selection technique should be used. It is worth knowing what the evidence currently supports: the HFEA assesses sperm selection including MACS — a technique that uses magnetic sorting to separate sperm by surface signals associated with damaged or dying cells — as having insufficient moderate- or high-quality evidence for improved chances of having a baby in male-factor infertility. That is a statement about the evidence base, not a recommendation for or against any individual couple; the decision belongs with your clinician.
Other topics that belong in the same conversation:
- Whether ICSI is planned and why, given the semen analysis and fragmentation result.
- Whether repeat fragmentation testing or a different assay would change anything, and what the clinic would do differently based on the answer.
- Whether surgical sperm retrieval is being considered, and on what grounds.
- How the laboratory decides between fresh transfer and culture to blastocyst, and how embryo biopsy for PGT-A fits when few embryos are expected.
That last point deserves its own discussion. PGT-A is a screening test, not a treatment, and it does not create embryos or improve an individual embryo. When embryo numbers are likely to be small, the value of testing depends on how many embryos are available and what a result would change about the transfer plan. It is reasonable to ask the clinic to walk through that logic before committing. For background, see PGT for male factor infertility: when it helps and what it cannot do.
Sequencing the plan around a consultation that may change
Because both findings can shift the plan after results are reviewed, the practical sequence matters as much as the clinical one. A workable order for many international couples looks like this:
- Assemble records in one dated file, with assay details included.
- Request a remote consultation and send the file ahead, so the clinician can review before speaking rather than during the call.
- Ask for the plan in writing — protocol outline, monitoring expectations, laboratory approach, and what would trigger a change.
- Compare what is included in any quotation, marking anything unconfirmed, before committing to travel dates.
- Plan travel around the confirmed schedule, not around an assumed one, and keep some flexibility for monitoring-dependent decisions.
- Agree the return-home handoff — which records you will receive, in what format, and who answers follow-up questions.
Step three is where many couples gain the most. A written plan is easier to compare across clinics and easier to revisit if the cycle takes an unexpected turn. If a cycle is cancelled or adjusted, having the original reasoning documented helps the next conversation. There is a practical guide to handling IVF cycle cancellation in Thailand that covers this scenario.
A worked planning situation
Consider a couple in their late thirties. The woman has a low AMH and no prior IVF cycle; the man has an elevated fragmentation index from a laboratory whose assay details are not yet in hand. A sensible first move is not to choose a clinic but to complete the file: request the full fragmentation report, confirm whether an antral follicle count has been done, and gather the semen analysis. With those in hand, a remote consultation can address three things at once — expected egg numbers and monitoring plan, sperm handling and ICSI rationale, and whether PGT-A would change anything given likely embryo numbers.
Only after that conversation does it make sense to compare quotations and fix travel dates. The plan may still change after the first monitoring scan; that is normal, and it is why the written plan and the return-home handoff are worth agreeing early.
Where the coordinator’s role ends
Coordination support can help organise records, request appointments and remote consultations, assist with travel and language needs around confirmed appointments, and arrange records handover after you return home. It does not interpret results, recommend a protocol, or estimate your chances — those are clinical judgements. The boundary is simple: bring the questions, and let the licensed clinicians answer them.
Evidence trail
Sources & verification
Review current primary information and reconfirm provider services, fees and eligibility before booking.
01HFEA: Sperm DNA fragmentation and sperm-selection evidence ↗Your next practical step
Bring your coordination questions.
Ask about appointments, records, travel or the practical arrangements for your visit.



